Post-mortem studies of MDD patients, albeit still in a preliminary phase of investigation, report increased neural CB1 receptor mRNA and protein in the PFC, consistent with a model of elevated FAAH activity, reduced AEA; and less stimulation of CB1 receptors with their upregulation [11, 12]. The gene discussed is FAAH; the disease is major depressive disorder.